Paul Lauterbur dies

The chemist and physicist won the Nobel Prize for helping develop MRI

Written byKirsten Weir
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
Paul Lauterbur, who shared the 2003 Nobel Prize in Physiology or Medicine for developing a way to create noninvasive images of the human body with nuclear magnetic resonance (NMR), died from kidney disease on March 27. He was 77.
"He's really considered the father of the field of MRI," Charles Springer, director of the Advanced Imaging Research Center at Oregon Health and Science University, told The Scientist. Lauterbur first became interested in nuclear magnetic resonance spectroscopy while working at the Mellon Institute and simultaneously taking graduate courses in Chemistry at the University of Pittsburgh. He joined the faculty of the State University of New York in Stony Brook in 1969 and continued to explore NMR, using the technique to study carbon-13. In those early days of NMR, chemists studied the properties of atoms and molecules by analyzing them under a magnetic field. They strove to create a uniform magnetic field, which produced a clear signal from the molecules. But Lauterbur realized that the blurry images created by a non-uniform magnetic field actually contained spatial information. "It was the secret that was hiding in plain sight, and he was the one to see it," Springer said.The first magnetic resonance images Lauterbur created pictured test tubes of water and heavy water, said David Hanson, a physical chemist at Stony Brook University in New York. Quickly grasping the potential biological applications, Hanson said, Lauterbur next sought to image a living creature, but had to find one that would fit inside the small NMR tubes. He settled on a clam -- a subject suggested by his daughter during a trip to the beach. Those early experiments didn't impress many people, Hanson said. "The images looked like the same kinds of things you could see with a camera," he said. But "Paul understood that these were proof-of-principle experiments and he had a vision for where they would lead." Others weren't as quick to understand the technology's potential. Lauterbur's first paper on the subject was rejected by Nature. Determined, he revised and resubmitted, and the paper was published in 1973. It has since been cited more than 1,000 times. (Nearly 100 of his papers have together accumulated more than 3,000 citations.) From the start, Lauterbur was confident in the technology and its applications, Charles Slichter, a physicist at the University of Illinois at Urbana-Champaign, told The Scientist. "It wasn't conceit, but he'd thought about it quite deeply," he said. "He realized that the potential applications would be big." By the time Lauterbur joined the University of Illinois at Urbana-Champaign in 1985, the importance of MRI to medical imaging was clear. Still he worked to improve the technology, said Timothy Peck, who worked with Lauterbur as a University of Illinois graduate student and is now division president of Protasis Corporation in Savoy, IL. "Paul was always thinking about what could be done to MRI to make it more useful."In 2003, Lauterbur shared the Nobel Prize in Physiology or Medicine with Sir Peter Mansfield of the University of Nottingham, another early pioneer in the development of the imaging technique. The prize sparked a high-profile dispute, however, in which NMR researcher Raymond Damadian argued that some of his experiments predated Lauterbur's, and he should share credit for the invention. Yet according to Peck, Lauterbur "rose above" the disagreement and didn't speak out about it. In addition to the Nobel Prize, Lauterbur received numerous awards for his contribution to medical imaging, including the National Medal of Science. He was also a member of the National Inventors Hall of Fame. "In so many cases MRI has saved peoples' lives," Slichter said. "The importance of his contribution to humanity is enormous."Kirsten Weir mail@the-scientist.comImage: Courtesy of the University of Illinois at Urbana-ChampaignLinks within this article:S. Pincock, "MRI scientists win Nobel Prize," The Scientist, October 6, 2003. http://www.the-scientist.com/article/display/21658Charles Springer http://www.ohsu.edu/airc/group/cs/csswebpage.html?fixDavid Hanson http://www.pogil.org/personnel/Hanson.phpCharles Slichter http://www.physics.uiuc.edu/people/Slichter/index.htmThe Nobel Prize in Physiology or Medicine 2003 http://nobelprize.org/nobel_prizes/medicine/laureates/2003/index.htmlS. Pincock, "Not winning the Nobel," The Scientist, October 8, 2003. http://www.the-scientist.com/article/display/21665/
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform